<b>Dataset of a </b><b>phase Ib clinical study: </b><b>rapid regression of high-risk carotid hemorrhagic </b><b>plaques with sonodynamic therapy</b>

<p dir="ltr">Carotid plaques with intraplaque hemorrhage (IPH) accelerate plaque progression and increase the risk of cerebrovascular events; however, safe and effective therapeutic strategies remain unavailable. We report the results of macrophage-targeted sonodynamic therapy (SDT)...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Ye Tian (22423790) (author)
مؤلفون آخرون: Qiannan Li (22405660) (author), Huiyu Qiao (22423761) (author), Tengyu Wang (22423762) (author), Ying Liu (22423764) (author), Tianyi Zhang (22423772) (author), Jiemei Yang (22423775) (author), Hao Hu (22423778) (author), Shuyuan Guo (22423779) (author), Shuyuan Guo (22423782) (author), Liuying Wang (15287193) (author), Zixin Zhang (22423785) (author), Lichen Zhang (22423788) (author), Xihai Zhao (11926730) (author)
منشور في: 2025
الموضوعات:
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
_version_ 1852015814494912512
author Ye Tian (22423790)
author2 Qiannan Li (22405660)
Huiyu Qiao (22423761)
Tengyu Wang (22423762)
Ying Liu (22423764)
Tianyi Zhang (22423772)
Jiemei Yang (22423775)
Hao Hu (22423778)
Shuyuan Guo (22423779)
Shuyuan Guo (22423782)
Liuying Wang (15287193)
Zixin Zhang (22423785)
Lichen Zhang (22423788)
Xihai Zhao (11926730)
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author_facet Ye Tian (22423790)
Qiannan Li (22405660)
Huiyu Qiao (22423761)
Tengyu Wang (22423762)
Ying Liu (22423764)
Tianyi Zhang (22423772)
Jiemei Yang (22423775)
Hao Hu (22423778)
Shuyuan Guo (22423779)
Shuyuan Guo (22423782)
Liuying Wang (15287193)
Zixin Zhang (22423785)
Lichen Zhang (22423788)
Xihai Zhao (11926730)
author_role author
dc.creator.none.fl_str_mv Ye Tian (22423790)
Qiannan Li (22405660)
Huiyu Qiao (22423761)
Tengyu Wang (22423762)
Ying Liu (22423764)
Tianyi Zhang (22423772)
Jiemei Yang (22423775)
Hao Hu (22423778)
Shuyuan Guo (22423779)
Shuyuan Guo (22423782)
Liuying Wang (15287193)
Zixin Zhang (22423785)
Lichen Zhang (22423788)
Xihai Zhao (11926730)
dc.date.none.fl_str_mv 2025-10-14T03:08:46Z
dc.identifier.none.fl_str_mv 10.6084/m9.figshare.30343447.v1
dc.relation.none.fl_str_mv https://figshare.com/articles/dataset/_b_Dataset_of_a_b_b_phase_Ib_clinical_study_b_b_rapid_regression_of_high-risk_carotid_hemorrhagic_b_b_plaques_with_sonodynamic_therapy_b_/30343447
dc.rights.none.fl_str_mv CC BY 4.0
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Radiology and organ imaging
Carotid high-risk plaque
Sonodynamic therapy
Plaque regression
Maximum wall thickness
Intraplaque hemorrhage
dc.title.none.fl_str_mv <b>Dataset of a </b><b>phase Ib clinical study: </b><b>rapid regression of high-risk carotid hemorrhagic </b><b>plaques with sonodynamic therapy</b>
dc.type.none.fl_str_mv Dataset
info:eu-repo/semantics/publishedVersion
dataset
description <p dir="ltr">Carotid plaques with intraplaque hemorrhage (IPH) accelerate plaque progression and increase the risk of cerebrovascular events; however, safe and effective therapeutic strategies remain unavailable. We report the results of macrophage-targeted sonodynamic therapy (SDT) for treating patients with high-risk carotid plaques. Twelve participants with 24 plaques (15 with IPH and 9 without IPH) underwent a single SDT. Follow-up assessments were conducted at 1, 3, 6, and 9 months. The safety endpoints demonstrated no occurrence of serious adverse events. The primary endpoint demonstrated a significant decrease in maximum wall thickness (MaxWT) at 1 month post-SDT in all plaques, particularly IPH plaques. The secondary endpoint revealed a decreasing trend in IPH volume at 3 months post-SDT. The exploratory analysis revealed that SDT may suppress neovascularization, reduce inflammation, and promote dead cell clearance. Collectively, SDT safely and effectively promotes the rapid regression of carotid plaques with IPH. The study is registered on ClinicalTrials.gov (NCT03871725).</p>
eu_rights_str_mv openAccess
id Manara_c2c19b8c87dc83aa814e769bb736609e
identifier_str_mv 10.6084/m9.figshare.30343447.v1
network_acronym_str Manara
network_name_str ManaraRepo
oai_identifier_str oai:figshare.com:article/30343447
publishDate 2025
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv CC BY 4.0
spelling <b>Dataset of a </b><b>phase Ib clinical study: </b><b>rapid regression of high-risk carotid hemorrhagic </b><b>plaques with sonodynamic therapy</b>Ye Tian (22423790)Qiannan Li (22405660)Huiyu Qiao (22423761)Tengyu Wang (22423762)Ying Liu (22423764)Tianyi Zhang (22423772)Jiemei Yang (22423775)Hao Hu (22423778)Shuyuan Guo (22423779)Shuyuan Guo (22423782)Liuying Wang (15287193)Zixin Zhang (22423785)Lichen Zhang (22423788)Xihai Zhao (11926730)Radiology and organ imagingCarotid high-risk plaqueSonodynamic therapyPlaque regressionMaximum wall thicknessIntraplaque hemorrhage<p dir="ltr">Carotid plaques with intraplaque hemorrhage (IPH) accelerate plaque progression and increase the risk of cerebrovascular events; however, safe and effective therapeutic strategies remain unavailable. We report the results of macrophage-targeted sonodynamic therapy (SDT) for treating patients with high-risk carotid plaques. Twelve participants with 24 plaques (15 with IPH and 9 without IPH) underwent a single SDT. Follow-up assessments were conducted at 1, 3, 6, and 9 months. The safety endpoints demonstrated no occurrence of serious adverse events. The primary endpoint demonstrated a significant decrease in maximum wall thickness (MaxWT) at 1 month post-SDT in all plaques, particularly IPH plaques. The secondary endpoint revealed a decreasing trend in IPH volume at 3 months post-SDT. The exploratory analysis revealed that SDT may suppress neovascularization, reduce inflammation, and promote dead cell clearance. Collectively, SDT safely and effectively promotes the rapid regression of carotid plaques with IPH. The study is registered on ClinicalTrials.gov (NCT03871725).</p>2025-10-14T03:08:46ZDatasetinfo:eu-repo/semantics/publishedVersiondataset10.6084/m9.figshare.30343447.v1https://figshare.com/articles/dataset/_b_Dataset_of_a_b_b_phase_Ib_clinical_study_b_b_rapid_regression_of_high-risk_carotid_hemorrhagic_b_b_plaques_with_sonodynamic_therapy_b_/30343447CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/303434472025-10-14T03:08:46Z
spellingShingle <b>Dataset of a </b><b>phase Ib clinical study: </b><b>rapid regression of high-risk carotid hemorrhagic </b><b>plaques with sonodynamic therapy</b>
Ye Tian (22423790)
Radiology and organ imaging
Carotid high-risk plaque
Sonodynamic therapy
Plaque regression
Maximum wall thickness
Intraplaque hemorrhage
status_str publishedVersion
title <b>Dataset of a </b><b>phase Ib clinical study: </b><b>rapid regression of high-risk carotid hemorrhagic </b><b>plaques with sonodynamic therapy</b>
title_full <b>Dataset of a </b><b>phase Ib clinical study: </b><b>rapid regression of high-risk carotid hemorrhagic </b><b>plaques with sonodynamic therapy</b>
title_fullStr <b>Dataset of a </b><b>phase Ib clinical study: </b><b>rapid regression of high-risk carotid hemorrhagic </b><b>plaques with sonodynamic therapy</b>
title_full_unstemmed <b>Dataset of a </b><b>phase Ib clinical study: </b><b>rapid regression of high-risk carotid hemorrhagic </b><b>plaques with sonodynamic therapy</b>
title_short <b>Dataset of a </b><b>phase Ib clinical study: </b><b>rapid regression of high-risk carotid hemorrhagic </b><b>plaques with sonodynamic therapy</b>
title_sort <b>Dataset of a </b><b>phase Ib clinical study: </b><b>rapid regression of high-risk carotid hemorrhagic </b><b>plaques with sonodynamic therapy</b>
topic Radiology and organ imaging
Carotid high-risk plaque
Sonodynamic therapy
Plaque regression
Maximum wall thickness
Intraplaque hemorrhage